Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Debt Ratio (2018 - 2022)

Theravance Biopharma (TBPH) has disclosed Debt Ratio for 5 consecutive years, with 1.1 as the latest value for Q2 2022.

  • Quarterly Debt Ratio rose 23.38% to 1.1 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 1.1 through Jun 2022, up 23.38% year-over-year, with the annual reading at 1.04 for FY2021, 23.9% up from the prior year.
  • Debt Ratio for Q2 2022 was 1.1 at Theravance Biopharma, down from 1.11 in the prior quarter.
  • The five-year high for Debt Ratio was 1.11 in Q1 2022, with the low at 0.41 in Q4 2018.
  • Average Debt Ratio over 5 years is 0.76, with a median of 0.75 recorded in 2020.
  • The sharpest move saw Debt Ratio skyrocketed 67.0% in 2021, then grew 7.29% in 2022.
  • Over 5 years, Debt Ratio stood at 0.41 in 2018, then soared by 36.81% to 0.56 in 2019, then soared by 49.18% to 0.84 in 2020, then increased by 23.9% to 1.04 in 2021, then rose by 5.99% to 1.1 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 1.1, 1.11, and 1.04 for Q2 2022, Q1 2022, and Q4 2021 respectively.